Followers | 3183 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
Friday, August 05, 2022 10:03:04 AM
Recent ACON News
- Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain • GlobeNewswire Inc. • 04/25/2024 01:14:37 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/06/2024 09:09:09 PM
- Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Aclarion Announces Closing of $3.0 Million Public Offering • GlobeNewswire Inc. • 02/27/2024 08:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 07:00:20 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/27/2024 03:46:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/27/2024 05:15:34 AM
- Aclarion Announces Pricing of $3.0 Million Public Offering • GlobeNewswire Inc. • 02/26/2024 02:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/23/2024 04:46:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/21/2024 08:02:48 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 10:32:26 PM
- Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/01/2024 10:16:49 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/31/2024 10:26:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:04:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:53:59 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2024 09:48:49 PM
- Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD • GlobeNewswire Inc. • 01/22/2024 01:00:00 PM
- Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution • GlobeNewswire Inc. • 01/17/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/12/2024 09:15:59 PM
- Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/04/2024 01:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:00:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM